About SeqLL, Inc. 
SeqLL, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 7 Schemes (1.1%)
Foreign Institutions
Held by 6 Foreign Institutions (0.15%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
103 Million
(Quarterly Results - Jun 2025)
Net Profit:
-11 Million
Pharmaceuticals & Biotechnology
USD 210 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-3.51
457.44%
-9.50






